Wbi Investments, Inc. Abb Vie Inc. Transaction History

Wbi Investments, Inc.

$469 Million
Q1 2024

A detailed history of Wbi Investments, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Wbi Investments, Inc. holds 8,952 shares of ABBV stock, worth $1.49 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

8,952

Previous 10,958 18.31%

Holding current value

$1.49 Million

Previous $1.7 Million 4.0%

% of portfolio

0.35%

Previous 0.34%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $320,598 - $365,292	-2,006 Reduced 18.31%	8,952 $1.63 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $1.51 Million - $1.7 Million	10,958 New	10,958 $1.7 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $4.93 Million - $5.68 Million	-34,119 Reduced 77.51%	9,897 $1.58 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $6.09 Million - $7.3 Million	44,016 New	44,016 $7.12 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $1.06 Million - $1.35 Million	-7,698 Reduced 13.05%	51,285 $7.63 Million

Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $7.34 Million - $9.1 Million	-55,583 Reduced 48.52%	58,983 $9.33 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $9.07 Million - $11.5 Million	84,439 Added 280.28%	114,566 $15.3 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $3.19 Million - $3.62 Million	-29,969 Reduced 49.87%	30,127 $3.17 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $6.31 Million - $7.02 Million	59,929 Added 35885.63%	60,096 $6.77 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $11.1 Million - $12.3 Million	-105,239 Reduced 99.84%	167 $6.77 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $8.77 Million - $9.66 Million	85,767 Added 436.72%	105,406 $11.4 Million
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $159,289 - $215,057	-1,979 Reduced 9.15%	19,639 $2.1 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $15,291 - $17,947	178 Added 0.83%	21,618 $1.89 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $1.57 Million - $2.1 Million	21,440 New	21,440 $2.11 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $9.71 Million - $14.7 Million	-150,512 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $226,848 - $283,836	-3,145 Reduced 2.05%	150,512 $13.3 Million
Q3 2019 Oct 29, 2019	BUY	$62.98 - $75.72 $5.28 Million - $6.35 Million	83,909 Added 120.3%	153,657 $11.6 Million
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $4.58 Million - $5.86 Million	69,748 New	69,748 $5.07 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $8.07 Million - $10.8 Million	-87,746 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $7.86 Million - $8.62 Million	87,746 New	87,746 $8.49 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $14.4 Million - $18.4 Million	-205,733 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	205,733	205,733 $14.9 Million

Others Institutions Holding ABBV

# of Institutions

3,654

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wbi Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wbi Investments, Inc. with notifications on news.

Account

Wbi Investments, Inc. Abb Vie Inc. Transaction History